Swiss Pharma sued after malaria drug gives ex-corper life threatening skin condition

Swiss Pharma sued by corper

Miss Morenike, an ex-Batch B youth corps member, who served in 2014 has dragged Swiss Pharma Nigeria Limited to court, after she contracted Steven Johnsons Syndrome, a life-threatening skin condition, after using Fansidar (also known as Swidar), an anti malarial drug produced by the pharmaceutical company.

Read also: NYSC sued over alleged N2.4bn illegal fees

In the suit filed before an Ikeja High Court, the claimant, who graduated from a Scotish university where she read Bio Med, and came to Nigeria for the mandatory national youth service, averred that while she was at the NYSC orientation camp she took Fansidar that was given to her by NYSC.

Consequently, she said she developed blisters on her arms and hands, adding that condition grew worse to the point that she was salivating uncontrollably and blood was coming out from the pores of her skin.

Mrs. Olamide Olorunda, the claimant’s mother is a co-claimant in the suit.
They are asking the court for an order of perpetual injunction restraining the defendant from further manufacturing the anti malarial drug, Swidar, and also requiring the defendant to show pictures on its products leaflets of what a person with SJS, which is a known side effect of the drug.

They are equally claiming the sum of N207 million in special and general damages from Swiss Pharma Nigeria Limited.

Justice Oke Lawal, who is presiding over the matter, adjourned it till February 8, 2017 for further hearing of the suit.

Stevens–Johnson syndrome, a life-threatening skin condition, is a form of toxic epidermal necrolysis, in which cell death causes the epidermis to separate from the dermis.

Sign up for our daily newsletter

Get the latest news delivered straight to your inbox every day. Stay informed with the Orijo Reporter's leading coverage of Nigerian and world news.


Please enter your comment!
Please enter your name here